Serialization process is not a new one in other industries on global level. Automotive and banking industry have already implemented it.
No, pharmaceutical industry must do the same.
- Do we need to be afraid of that procedure?
- Do we need the serilaization at all taking into consideration relatively low rate of counterfeiting of medicinal products in the EU?
- How much will that cost us?
- And above all, what are teh benefits of such procedure?
EC has already issued an official guideline: